{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:09:08Z","timestamp":1785863348853,"version":"3.56.0"},"reference-count":22,"publisher":"The Journal of Rheumatology","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To summarize the endorsement of measures of patient-reported outcome (PRO) domains in chronic gout at the 2010 Outcome Measures in Rheumatology Meeting (OMERACT 10).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>During the OMERACT 10 gout workshop, validation data were presented for key PRO domains including pain [pain by visual analog scale (VAS)], patient global (patient global VAS), activity limitation [Health Assessment Questionnaire-Disability Index (HAQ-DI)], and a disease-specific measure, the Gout Assessment Questionnaire version 2.0 (GAQ v2.0). Data were presented on all 3 aspects of the OMERACT filters of truth, discrimination, and feasibility. One PRO, health-related quality of life measurement with the Medical Outcomes Study Short-form 36 (SF-36), was previously endorsed at OMERACT 9.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>One measure for each of the 3 PRO of pain, patient global, and activity limitation was endorsed by &gt; 70% of the OMERACT delegates to have appropriate validation data. Specifically, pain measurement by VAS was endorsed by 85%, patient global assessment by VAS by 73%, and activity limitation by HAQ-DI by 71%. GAQ v2.0 received 30% vote and was not endorsed due to several concerns including low internal consistency and lack of familiarity with the measure. More validation studies are needed for this measure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>With the endorsement of one measure each for pain, patient global, SF-36, and activity limitation, all 4 PRO for chronic gout have been endorsed. Future validation studies are needed for the disease-specific measure, GAQ v2.0. Validation for PRO for acute gout will be the focus of the next validation exercise for the OMERACT gout group.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.110271","type":"journal-article","created":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T16:52:04Z","timestamp":1309539124000},"page":"1452-1457","source":"Crossref","is-referenced-by-count":91,"title":["Patient-reported Outcomes in Chronic Gout: A Report from OMERACT 10"],"prefix":"10.3899","volume":"38","author":[{"given":"JASVINDER A.","family":"SINGH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WILL J.","family":"TAYLOR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LEE S.","family":"SIMON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PUJA P.","family":"KHANNA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LISA K.","family":"STAMP","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FIONA M.","family":"McQUEEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TUHINA","family":"NEOGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANGELO L.","family":"GAFFO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICHAEL A.","family":"BECKER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PATRICIA A.","family":"MacDONALD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OMAR","family":"DABBOUS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VIBEKE","family":"STRAND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NICOLA D.","family":"DALBETH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DANIEL","family":"ALETAHA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. LAWRENCE","family":"EDWARDS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"H. RALPH","family":"SCHUMACHER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2011,7,1]]},"reference":[{"key":"2018112909263853000_38.7.1452.1","unstructured":"U.S. Department of Health and Human Services . Food and Drug Administration. Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to support labeling claims. [Internet. Accessed 15 March 2011.] Rockville, Maryland; 2009. Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf"},{"key":"2018112909263853000_38.7.1452.2","unstructured":"NIH. PROMIS . Patient-Reported Outcomes Measurement Information System: dynamic tools to measure health outcomes from the patient perspective. [Internet. Accessed March 15, 2011.]. National Institutes of Health. Available from: http:\/\/www.nihpromis.org\/default.aspx."},{"key":"2018112909263853000_38.7.1452.3","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181945d2c"},{"key":"2018112909263853000_38.7.1452.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00173.x"},{"key":"2018112909263853000_38.7.1452.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-008-0039-0"},{"key":"2018112909263853000_38.7.1452.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22014"},{"key":"2018112909263853000_38.7.1452.7","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-009-0022-4"},{"key":"2018112909263853000_38.7.1452.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.081604"},{"key":"2018112909263853000_38.7.1452.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.10.1104"},{"key":"2018112909263853000_38.7.1452.10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090370"},{"key":"2018112909263853000_38.7.1452.11","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem178"},{"key":"2018112909263853000_38.7.1452.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088351"},{"key":"2018112909263853000_38.7.1452.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050373"},{"key":"2018112909263853000_38.7.1452.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.24209"},{"key":"2018112909263853000_38.7.1452.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1963.03060120024016"},{"key":"2018112909263853000_38.7.1452.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230202"},{"key":"2018112909263853000_38.7.1452.17","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-010-9690-9"},{"key":"2018112909263853000_38.7.1452.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.23575"},{"key":"2018112909263853000_38.7.1452.19","first-page":"620","article-title":"The Health Assessment Questionnaire Disability Index is a valid measure of physical function in gout","volume":"26","author":"Taylor","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909263853000_38.7.1452.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2006.01104.x"},{"key":"2018112909263853000_38.7.1452.21","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080506"},{"key":"2018112909263853000_38.7.1452.22","doi-asserted-by":"crossref","unstructured":"Khanna D Sarkin AJ Khanna PP Shieh MM Kavanaugh AF Terkeltaub RA Responsiveness to change and minimally important differences of the gout impact scale in a randomized controlled trial 2010. Rheumatology 2011 Mar 3. [Epub ahead of print]","DOI":"10.1093\/rheumatology\/ker023"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.110271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T16:45:48Z","timestamp":1560357948000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.110271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,1]]},"published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.3899\/jrheum.110271"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.110271","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}